Clinical Trials Breakdown

GLP 1s for neurodegenerative diseases GLP-1 receptor agonists (GLP-1 RAs), originally developed for type 2 diabetes and obesity, are now being investigated for their potential neuroprotective effects in neurodegenerative diseases,…